Sensus Healthcare, Inc.
A maker of non-invasive medical devices, Sensus Healthcare builds the SRT-100 system that dermatologists use to treat common skin cancers and keloid scars with gentle, low-energy X-rays that spare healthy tissue beneath the skin. Founded around 2010 by Joseph Sardano in Boca Raton, Florida, the company grew out of his long career in medical technology at firms like GE and Siemens. Its name plays on "sensible"—its pitch being a common-sense, surgery-free way to treat skin problems.
Bought 90.0K · Sold 512.4K
Sold 63.3K
Sold 70.1K
Sold 181.7K
Granted 50.0K · Bought 97.1K · Sold 10.0K
Bought 76.2K
Granted 166.7K · Sold 4.5K
Granted 155.0K · Bought 9.0K · Sold 5.0K
Granted 30.0K · Bought 20.0K · Sold 50.0K
Granted 76.6K
Granted 30.0K · Bought 20.0K · Sold 20.0K
Granted 59.0K · Bought 501 · Sold 9.0K
Granted 30.0K
Granted 20.0K · Sold 10.0K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Sardano Joseph CCHIEF EXECUTIVE OFFICER, Director · 49 transactions | — | 1.22M | — | 90.0K | 512.4K |
| Fishman KalmanCHIEF TECHNOLOGY OFFICER · 29 transactions | — | 931.0Kas of Mar 2019 | — | — | 63.3K |
| Golin RichardEXECUTIVE VICE PRESIDENT · 31 transactions | — | 924.2Kas of Mar 2019 | — | — | 70.1K |
| Cohen Stephen BradEXECUTIVE VICE PRESIDENT · 38 transactions | — | 830.6Kas of Dec 2021 | — | — | 181.7K |
| McCall William HDirector · 23 transactions | — | 355.7Kas of Dec 2024 | 50.0K | 97.1K | 10.0K |
| Sachetta EricDirector · 6 transactions | — | 211.4K | — | 76.2K | — |
| Levine ArthurCHIEF FINANCIAL OFFICER · 29 transactions | — | 186.7Kas of Jun 2019 | 166.7K | — | 4.5K |
| Sardano MichaelPRESIDENT AND GENERAL COUNSEL, Director · 24 transactions | — | 159.8K | 155.0K | 9.0K | 5.0K |
| O'Rear SamuelDirector · 7 transactions | — | 143.6Kas of May 2023 | 30.0K | 20.0K | 50.0K |
| Petrelli Anthony BenedictDirector · 5 transactions | — | 66.5Kas of Dec 2024 | 76.6K | — | — |
| Heinrich JohnDirector · 6 transactions | — | 59.9Kas of May 2024 | 30.0K | 20.0K | 20.0K |
| Rampolla JavierCHIEF FINANCIAL OFFICER · 13 transactions | — | 40.7Kas of Feb 2025 | 59.0K | 501 | 9.0K |
| Cornish MeganDirector · 2 transactions | — | 32.0Kas of Dec 2024 | 30.0K | — | — |
| Martinez MagdalenaCHIEF OPERATING OFFICER · 1 transaction | — | 12.8K | — | — | — |
| Soro NicolasCHIEF OPERATING OFFICER · 5 transactions | — | 3.5Kas of Mar 2022 | 20.0K | — | 10.0K |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over all recorded history: -623.1K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.